Compare Consolidated Edison, Inc. (ED) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Consolidated Edison, Inc. vs Revvity Inc — how do they compare? Consolidated Edison, Inc. trades at $107.51 (market cap $39.76B), while Revvity Inc trades at $117.6 (market cap $12.91B). The key difference: Consolidated Edison, Inc. is far larger — about 3.1× Revvity Inc's market cap, and Consolidated Edison, Inc. pays the higher dividend (3.27%). Which is the better fit depends on your goals.
| ED | RVTY | |
|---|---|---|
Market Cap | $39.76B | $12.91B |
Sector | Utilities | Technology |
52-Week High | $115.46 | $117.75 |
52-Week Low | $95.37 | $82.26 |
Enterprise Value | $66.61B | $15.23B |
Dividend Yield | 3.27% | 0.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Consolidated Edison (ED) trades at $107.78, up 1.39% with mixed technical signals showing bearish moving averages but neutral oscillators. The utility company reported strong Q2 2026 earnings of $0.83 per share, beating estimates, with revenue growth driven by higher electric and gas rate bases. ED maintains a stable dividend yield with consistent quarterly payments of $0.89 and reaffirmed 2026 earnings guidance amid rising power demand from data centers.
ED offers defensive exposure with predictable returns supported by its regulated monopoly, but faces execution risks from grid upgrades and interest rate sensitivity. Analyst consensus is cautious with 63% hold ratings and a $103.25 price target below current levels, suggesting limited near-term upside despite solid fundamentals and growing power demand trends.
RVTY trades at $117.88, up 1.6% today, with a bullish technical outlook and strong earnings momentum after beating Q2 2026 EPS estimates. The stock is near the consensus price target of $120.50, supported by a 51.72% analyst buy rating. Recent news highlights product launches like the SuperFlex prenatal system and investor conference participation, reinforcing growth prospects in diagnostics and biotech tools.
The outlook remains positive with revenue stability and margin strength, but elevated P/E of 55.64 poses valuation risk. Key opportunities include diagnostic demand and AI-driven workflows, while risks involve competitive pressures and execution challenges. Net cash flow turned positive in 2026, signaling improved financial health.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Consolidated Edison, Inc.
Con Ed is a holding company for Consolidated Edison of New York, or CECONY, and Orange & Rockland, or O&R. These utilities provide steam, natural gas, and electricity to customers in southeastern New York—including New York City—and small parts of New Jersey. The two utilities will generate nearly all of Con Ed's earnings once it closes the sale of its clean energy business to RWE. Con Ed's clean energy business owns the second-largest portfolio of utility-scale solar projects in the U.S. Following the sale, Con Ed's only non-utility earnings will come from investments in gas and electric transmission.
Read more on ED →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
